GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human pim-1 kinase in complex with a thiadiazolamine-indole inhibitor.

Analyse Crystal structure of human pim-1 kinase in complex with a… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4WT6
Type
protein
Length
273 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase pim-1
EC
2.7.11.1
UniProt
P11309
Ligands
3U6
Pockets
1 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase pim-1 (EC 2.7.11.1)protein27340% helix, 23% strandP11309

Ligands and binding sites

  • 3U6 · 6-[5-(5-amino-1,3,4-thiadiazol-2-yl)-1H-indol-3-yl]-N-cyclopentylpyridin-2-amine · ligand · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13700.700.82443U6

Compared structures

  • 4WT6 · Crystal structure of human Pim-1 kinase in complex with a thiadiazolamine-indole… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.